Hilde H. Steineger

Hilde H. Steineger, a co-founder of NorthSea Therapeutics B.V., formerly served as Head of Strategic Innovation Management in Nutrition and Health Division (EN), BASF and Head of Global Omega-3 innovation Management including; R&D, Medical affairs and Business Development. She has also served as Vice President, Head of Investor Relations for Pronova BioPharma, Senior Associate at Neomed Management and as a Senior Analyst at Nordea Securities. Dr. Hilde Steineger has broad scientific knowledge with a PhD in medical biochemistry from the University of Oslo in 2000 and an MSc in molecular biology/biotechnology from 1992.